Panel Rejects Zimmer's Dynesys Spine Stabilization Device
This article was originally published in The Gray Sheet
Executive Summary
FDA should not approve Zimmer's Dynesys spine stabilization system as a stand-alone treatment for degenerative spine-related leg pain due to insufficient safety and efficacy data, according to the agency's Orthopedic and Rehabilitation Devices Panel
You may also be interested in...
Semi-Rigid Spine Systems Will Escape PMAs, But Not Clinical Mandate
US FDA has completed a long-running effort to reclassify pedicle screw systems, which are widely used devices for spine fusion procedures. The final policy: all pedicle screws intended as an adjunct to fusion surgery are class II/special controls devices, but "semi-rigid" systems will require clinical data to support 510(k) clearance while more traditional, rigid systems will not.
Zimmer Leans On Hip/Knee Sales As Spine Business Continues Decline In Q4
Zimmer expects sales of hip and knee devices to grow in the mid-single digits in 2010, including revenues from two recently launched hip systems, the MMC and Continuum acetabular cups
Zimmer Leans On Hip/Knee Sales As Spine Business Continues Decline In Q4
Zimmer expects sales of hip and knee devices to grow in the mid-single digits in 2010, including revenues from two recently launched hip systems, the MMC and Continuum acetabular cups